SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015116
Filing Date
2022-04-20
Accepted
2022-04-20 12:22:43
Documents
13
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20002718x1_def14a.htm DEF 14A 1608780
2 ny20002718x1_def14aimg001.jpg GRAPHIC 27515
3 ny20002718x1_def14aimg002.jpg GRAPHIC 14292
4 ny20002718x1_def14aimg003.jpg GRAPHIC 167266
5 ny20002718x1_def14aimg005.jpg GRAPHIC 93552
6 ny20002718x1_def14aimg006.jpg GRAPHIC 30303
7 ny20002718x1_def14aimg007.jpg GRAPHIC 101459
8 ny20002718x1_def14aimg008.jpg GRAPHIC 217867
9 ny20002718x1_def14aimg009.jpg GRAPHIC 1612892
10 ny20002718x1_def14aimg010.jpg GRAPHIC 94333
11 ny20002718x1_def14aimg011.jpg GRAPHIC 59305
12 ny20002718x1_def14aimg012.jpg GRAPHIC 75961
13 ny20002718x1_def14aimg013.jpg GRAPHIC 55052
  Complete submission text file 0001140361-22-015116.txt   4993426
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19125 | Film No.: 22837149
SIC: 2834 Pharmaceutical Preparations